Retrospective evaluation of transhepatic biliary stent placement in patients undergoing hepaticojejunostomy

Cholecystectomy is one of the most common operations performed by surgeons all over the world. Bile duct injury (BDI) occurs in 0.2-0.6 % of cholecystectomies.

We aimed to investigate the effects of transhepatic transanastomotic stent use in patients who underwent Roux-en-Y hepaticojejunostomy due to iatrogenic bile duct injury. The study included 37 patients who underwent R&Y hepticojejunostomy anastomosis due to iatrogenic bile duct injury at the General Surgery Clinic of the Afyonkarahisar Health Sciences University Medical Faculty Hospital between January 2010 to July 2024.

A total of 37 hepaticojejunostomy patients were included in the study; 16 (%43.2) received transhepatic stent and 21 (%56.8) did not receive stent. No mortality occurred in any of the patients. It was observed that the rate of Bismuth Type-1 was statistically significantly higher in the group without stent placement and Bismuth Type-4 was statistically significantly higher in the group with stent placement (p<0.001). The mean timing time was 13.75±7.37 days in the group without stent placement and 4.00±3.30 days in the group with stent placement, which was significantly higher in the group without stent placement (p<0.001). No significant difference was observed between the groups in terms of complication development (p=0.933).

As a result, although we prefer the use of transanastomotic stents in bile duct reconstruction after biliary injury in selected cases, we think that studies with larger series are needed.